BMP2K and neoplasm: Moreover, the in vitro or in vivo activation of NK cells with immune stimulants (including cytokines, BiKE, and TriKE) or the genetic modification of NK cells with CAR constructs specific for tumor antigens are promising strategies for potentiating and redirecting NK cell response against tumor cells.